Broadcom delivered strong earnings guidance with its latest results, as CEO Hock Tan revealed a US$10 billion ASIC mass-production order from a major new customer outside the core hyperscale cloud ...

TL;DR: Broadcom secured a $10 billion custom ASIC contract from a major non-CSP client, with Apple, xAI, and ByteDance also in line. OpenAI's custom AI chip, produced with Broadcom and TSMC, aims to ...

Macquarie is weighing up whether to pay compensation to thousands of customers who lost money in the collapsed Shield Master Fund investment scheme, with the asset manager and banking giant locked in ...

Fitness Amazon has Adidas deals from just $9 — 23 must-have deals I'd shop on sneakers, apparel, gym bags and more Running Huge Asics sneaker sale is live from $49 — here's 15 back to school deals ...

ASIC has released the results of the latest adviser exam, with August’s pass mark improving on the sitting from a year ago. In the August exam, some 221 candidates sat the exam and 68 per cent of them ...

ASIC is celebrating an “important win” against Harvey Norman and lender Latitude over a misleading national advertising campaign that ran in newspapers, on radio and on television. Between 2020 and ...

The Australian understands Macquarie and the Australian Securities and Investments Commission have been in discussions for some weeks over a potential remediation program for the thousands of ...

The legendary partnership between Ronnie Fieg‘s Kith and ASICS is continuing its celebrated legacy. The Kith founder has previewed a new take on their most iconic silhouette via Instagram, the ...

Incredibly bouncy ride Versatile across different speeds More breathable, race-orientated upper than the Superblast 2 FF Turbo Squared foam is soft underfoot When I tell people I test running shoes ...

We recently published Jim Cramer Just Couldn’t Stop Talking About These 13 Stocks. Marvell Technology, Inc. (NASDAQ:MRVL) is one of the stocks Jim Cramer recently discussed. Marvell Technology, Inc.

Gift 5 articles to anyone you choose each month when you subscribe. Mayne Pharma and its advisers at investment bank Jefferies are under scrutiny from the corporate regulator, which has begun making ...